I. To compare the pharmacokinetics (PK) of oral and intravenous triapine. II. To determine metabolic complete response (mCR) rate of oral triapine in combination with cisplatin chemoradiation using fludeoxyglucose F 18 (18F-FDG)-positron emission tomography (PET) computed tomography (CT) at post-therapy (3-months).